Qiuhui Ding
Overview
Explore the profile of Qiuhui Ding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang M, Zheng Z, Ding Q, Su J, Xin Y, Jiang X
Front Pharmacol
. 2024 Oct;
15:1458819.
PMID: 39474615
Background And Aims: Portal vein tumor thrombus (PVTT) occurs frequently in hepatocellular carcinoma (HCC) patients. However, there is currently no satisfactory treatment. Radiotherapy (RT) and tyrosine kinase inhibitors (TKI) are...
2.
Zhang M, Ding Q, Bian C, Su J, Xin Y, Jiang X
Exp Cell Res
. 2023 Mar;
426(1):113563.
PMID: 36944406
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, with poor prognosis and high mortality. Early-stage HCC has no obvious clinical symptoms, and most patients are already at...
3.
Liu B, Liu H, Ma Y, Ding Q, Zhang M, Liu X, et al.
Cancer Med
. 2021 Aug;
10(18):6167-6188.
PMID: 34374490
Lung cancer is the leading cause of cancer-related death globally and poses a considerable threat to public health. Asia has the highest prevalence of epidermal growth factor receptor (EGFR) mutations...
4.
Ma Y, Liu H, Zhang M, Liu B, Ding Q, Zhang L, et al.
Ann Palliat Med
. 2021 Jul;
11(4):1533-1541.
PMID: 34263612
Leptomeningeal metastasis (LM) is a disastrous complication in lung cancer. LM patients with oncogene-addicted non-small cell lung cancer (NSCLC) have a relatively better prognosis than those with the wild-type counterpart;...